FdaApplication
ANDA 206122
Identifiers
- fda_app_no: ANDA206122
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2016-08-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE;ORAL |
1 product